Manufacturer
80 recalls in our database name LumiQuick Diagnostics Inc. as the manufacturing or recalling firm.
Of the 80 recalls from LumiQuick Diagnostics Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
LumiQuick Diagnostics is recalling Benzodiazepine Strips because they were shipped to US locations without required FDA clearances.
LumiQuick Diagnostics is recalling CK-MB Test Cards shipped to US locations without required FDA clearance.
LumiQuick Diagnostics is recalling MDMA/Ecstasy Test Cards because they were shipped to locations without required FDA clearance.
LumiQuick Diagnostics is recalling Tramadol Test Cards because they were shipped to US locations without required FDA approvals.
LumiQuick Diagnostics is recalling EDDP Test Cards because they were shipped to locations without required FDA approvals.